All Stories

  1. The tumour suppressor CDKN2A/p16INK4a regulates adipogenesis and bone marrow-dependent development of perivascular adipose tissue

    Article • Diabetes and Vascular Disease Research, September 2017, SAGE Publications

    Professor Bart Staels

  2. Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2017, Endocrine Society

    Professor Bart Staels, Dr Joel Theodore Haas

  3. NASH

    Article • Annual Review of Physiology, February 2016, Annual Reviews

    Dr Joel Theodore Haas, Professor Bart Staels

  4. Perilipin2/adipophilin and ApoA-1 team up to combat atherosclerosis

    Article • Cardiovascular Research, December 2015, European Society of Cardiology

    Professor Bart Staels

  5. The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice

    Article • Hepatology, October 2014, Wolters Kluwer Health

    Professor Bart Staels

  6. The dual peroxisome proliferator-activated receptor alpha/delta agonist GFT505 exerts anti-diabetic effects in db/db mice without peroxisome proliferator-activated receptor gamma–associated adverse cardiac effects

    Article • Diabetes and Vascular Disease Research, September 2014, SAGE Publications

    Professor Bart Staels

  7. Farnesoid X Receptor Inhibits the Transcriptional Activity of Carbohydrate Response Element Binding Protein in Human Hepatocytes

    Article • Molecular and Cellular Biology, March 2013, ASM Journals

    Professor Bart Staels